Inventor · disambiguated record
Paul S. Charifson
Also filed as: CHARIFSON PAUL · CHARIFSON PAUL S · CHARIFSON PAUL SCOTT
66 granted patents·27 pending applications·849 citations·filing 2000–2025
99Inventor score
Files withVERTEX PHARMA57PRETZEL THERAPEUTICS INC8XENON PHARMACEUTICALS INC7CHARIFSON PAUL6CHARIFSON PAUL S3
Top patents by PatentIndex Score
93 records- 0198US9376448B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Jun 28, 2016·46 cites·10 claims
- 0297US9925188B2DNA-PK inhibitors and uses thereofVERTEX PHARMA·Filed 2016·Granted Mar 27, 2018·24 cites·18 claims
- 0397US6632809B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2001·Granted Oct 14, 2003·63 cites·26 claims
- 0496US9592232B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Mar 14, 2017·24 cites·13 claims
- 0596US9518056B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Dec 13, 2016·16 cites·4 claims
- 0696US9394302B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Jul 19, 2016·19 cites·6 claims
- 0796US9051319B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Jun 9, 2015·24 cites·2 claims
- 0895US9359380B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Jun 7, 2016·19 cites·25 claims
- 0995US9340557B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted May 17, 2016·19 cites·26 claims
- 1095US9296701B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Mar 29, 2016·21 cites·17 claims
- 1195US8829007B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Sep 9, 2014·28 cites·2 claims
- 1294US9878993B2DNA-PK inhibitors for treatment of cancerVERTEX PHARMA·Filed 2016·Granted Jan 30, 2018·10 cites·7 claims
- 1394US9808459B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Nov 7, 2017·11 cites·8 claims
- 1494US9345708B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2014·Granted May 24, 2016·21 cites·16 claims
- 1594US8871774B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Oct 28, 2014·18 cites·29 claims
- 1694USRE40245EGyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Apr 15, 2008·36 cites·26 claims
- 1794US6531474B1Inhibitors of caspasesVERTEX PHARMA·Filed 2000·Granted Mar 11, 2003·62 cites·15 claims
- 1893US10786512B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·3 cites·8 claims
- 1993US8067606B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2009·Granted Nov 29, 2011·14 cites·24 claims
- 2092US10973830B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·3 cites·23 claims
- 2192US10076521B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Sep 18, 2018·7 cites·21 claims
- 2292US10039762B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2017·Granted Aug 7, 2018·7 cites·2 claims
- 2392US9908878B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Mar 6, 2018·8 cites·16 claims
- 2492US7414046B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2003·Granted Aug 19, 2008·35 cites·29 claims
- 2591US10501439B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Dec 10, 2019·5 cites·18 claims
- 2691US10442791B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Oct 15, 2019·5 cites·13 claims
- 2791US10391095B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Aug 27, 2019·5 cites·9 claims
- 2891US8193352B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2009·Granted Jun 5, 2012·11 cites·18 claims
- 2990US9987284B2Substituted benzooxadiazole DNA-PK inhibitorsVERTEX PHARMA·Filed 2016·Granted Jun 5, 2018·5 cites·23 claims
- 3090US8288537B2Caspase inhibitors and uses thereofGOLEC JULIAN M C·Filed 2011·Granted Oct 16, 2012·14 cites·8 claims
- 3189US10258627B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·4 cites·19 claims
- 3289US8034832B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2009·Granted Oct 11, 2011·13 cites·7 claims
- 3389US7582641B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Sep 1, 2009·21 cites·28 claims
- 3489US6608087B1Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2002·Granted Aug 19, 2003·29 cites·13 claims
- 3588US8188095B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2008·Granted May 29, 2012·11 cites·6 claims
- 3688US7618974B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Nov 17, 2009·21 cites·19 claims
- 3788US6632962B2Caspase inhibitors and uses thereofVERTEX PHARMA·Filed 2001·Granted Oct 14, 2003·28 cites·14 claims
- 3887US8426426B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2010·Granted Apr 23, 2013·10 cites·14 claims
- 3987US8404852B2Gyrase inhibitors and uses thereofCHARIFSON PAUL S·Filed 2011·Granted Mar 26, 2013·10 cites·13 claims
- 4087US7727992B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2003·Granted Jun 1, 2010·23 cites·2 claims
- 4187US7569591B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Aug 4, 2009·27 cites·2 claims
- 4287US7495014B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Feb 24, 2009·25 cites·24 claims
- 4386US12251387B2Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitorsVERTEX PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 4484US8481551B2Gyrase and topoisomerase IV inhibitorsLE TIRAN ARNAUD·Filed 2012·Granted Jul 9, 2013·13 cites·24 claims
- 4582US9937192B2Combination therapy to treat mycobacterium diseasesSPERO TRINEM INC·Filed 2017·Granted Apr 10, 2018·2 cites·16 claims
- 4682US2025051367A1Heterocycle-containing lonp1 inhibitor compounds, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4781US2025059213A1Lonp1 inhibitors, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4881US2025059214A1Amide-containing lonp1 inhibitor compounds, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4978US8969359B2Gyrase and topoisomerase IV inhibitorsVERTEX PHARMA·Filed 2013·Granted Mar 3, 2015·3 cites·25 claims
- 5077US2021236505A1Substituted quinoxaline dna-pk inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Paul S. Charifson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →